• Article metrics
  • Last updated: Thu, 29 Jan 2026 23:52:14 Z

Preoperative pembrolizumab (anti-PD-1 antibody) combined with chemoradiotherapy for esophageal squamous cell carcinoma: a phase 1/2 trial (PALACE-2)

Access & Citations

  • 5093
    Article Accesses
  • Not available
    Citations

Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.

Online attention

Altmetric score 1
  • 2 tweeters
  • 6 Mendeley

This article is in the 29th percentile (ranked 122,195th) of the 197,381 tracked articles of a similar age in all journals and the 24th percentile (ranked 31st) of the 45 tracked articles of a similar age in Signal Transduction and Targeted Therapy

View more on Altmetric

Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.